転移性大腸がんにおけるEGFR融合を標的とする: 19歳の患者のラザルス反応の症例報告
Annalice Gandini1,2, Hélène Blons1,3, Pierre Laurent-Puig1,3
1Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Paris, France.
JCO precision oncology
|September 4, 2025
まとめ
No abstract available in PubMed .
さらに関連する動画
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.9K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.9K
